Skip to content
Z Zendikt
Editorial verdict · Who it’s wrong for

Who shouldn’t buy Chainalysis?

A direct read on the buyers Chainalysis is the wrong fit for — sourced from the same editorial team that ranked the full AML (Anti-Money Laundering) Software category.

Worst for

Non-crypto AML buyers (use Sumsub, NICE Actimize, SAS, or Napier AI instead), small fintech with token exposure under $10M (TRM Labs or Elliptic cheaper), or buyers prioritizing post-2022 vendor stability above all else.

For context: who it IS for

Crypto exchanges, banks with crypto exposure, FinCEN-regulated VASPs, and law enforcement (50-50,000+ employees) needing the broadest blockchain coverage and enforcement-grade tracing.

Target size: 50-50,000+ · Crypto exchanges, banks with crypto exposure, FinCEN-regulated VASPs, law enforcement

Why we say this

Editorial pulled these weaknesses from Chainalysis’s product card in our Top 10 AML (Anti-Money Laundering) Software for 2026:

  • ! 2022 $8.6B valuation overhang; secondary-market valuations reportedly compressed
  • ! 2023-2024 layoffs of roughly 25% of staff
  • ! IPO timing pushed out; vendor-stability question for multi-year commits
  • ! Heavy LE-driven roadmap can underprioritize commercial exchange customers
  • ! Pricing meaningful and opaque

If Chainalysis is wrong for you, consider these instead

Same AML (Anti-Money Laundering) Software category, different best-fit buyer.

Related editorial

Last updated 2026-05-10. Editorial verdict based on the published Top 10 AML (Anti-Money Laundering) Software for 2026 ranking. Disagree? Tell us.